| Literature DB >> 35782193 |
Ephrem Berhe1, Will Ross2, Hale Teka1, Hiluf Ebuy Abraha1, Lewis Wall2.
Abstract
Haemodialysis is extremely limited in low-income countries. Access to haemodialysis is further curtailed in areas of active conflict and political instability. Haemodialysis in the Tigray region of Ethiopia has been dramatically affected by the ongoing civil war. Rapid assessment from the data available at Ayder Hospital's haemodialysis unit registry, 2015-2021, shows that enrollment of patients in the haemodialysis service has plummeted since the war broke out. Patient flow has decreased by 37.3% from the previous yearly average. This is in contrary to the assumption that enrollment would increase because patients could not travel to haemodialysis services in the rest of the country due to the complete blockade. Compared to the prewar period, the mortality rate has doubled in the first year after the war broke out, i.e., 28 deaths out of 110 haemodialysis recipients in 2020 vs. 43 deaths out of 81 haemodialysis recipients in the year 2021. These untoward outcomes reflect the persistent interruption of haemodialysis supplies, lack of transportation to the hospital, lack of financial resources, and the unavailability of basic medications due to the war and the ongoing economic and humanitarian blockade of Tigray in Northern Ethiopia. In the setting of this medical catastrophe, the international community should mobilize to advocate for resumption of life-saving haemodialysis treatment in Ethiopia's Tigray region and put pressure on the Ethiopian government to allow the passage of life-saving medicines, essential medical equipment, and consumables for haemodialysis into Tigray.Entities:
Year: 2022 PMID: 35782193 PMCID: PMC9249476 DOI: 10.1155/2022/8141548
Source DB: PubMed Journal: Int J Nephrol
Figure 1The area of conflict in Tigray region, Northern Ethiopia. Google Maps 2020.
Sociodemographic and clinical characteristics of the study participants, Ayder Comprehensive Specialized Hospital, Mekelle, Northern Ethiopia, 2021 (n = 69).
| Characteristics | All cases | Outcomes | |
|---|---|---|---|
| Event | Censored | ||
| Age in years (mean (SD)) | 40.5 (19.1) | 47.4 (18.0) | 32.5 (17.5) |
| Sex, | |||
| Male | 39 (56.5) | 22 (56.4) | 17 (43.6) |
| Female | 30 (43.5) | 15 (50.0) | 15 (50.0) |
| Address, | |||
| Tigray | 65 (94.2) | 34 (52.3) | 31 (47.7) |
| Others | 4 (5.8) | 3 (66.7) | 1 (33.3) |
| Type of kidney disease, | |||
| AKI | 27 (39.1) | 15 (55.6) | 12 (44.4) |
| CKD | 42 (60.9) | 22 (52.4) | 20 (47.6) |
| LOS in days (median (IQR)) | 32 (83) | 32 (55) | 30.5 (117.5) |
| Number of dialysis indications, | |||
| One indication | 25 (36.2) | 13 (52.0) | 12 (48.0) |
| Two indications | 37 (53.6) | 18 (48.7) | 19 (51.3) |
| Three indications | 7 (10.2) | 6 (85.7) | 1 (14.3) |
| Indication, | |||
| Uremic features | 51 (73.9) | 26 (51) | 25 (49) |
| Pulmonary edema | 28 (50.6) | 14 (50.0) | 14 (50.0) |
| Metabolic acidosis | 27 (39.1) | 21 (77.8) | 6 (22.2) |
| Refractory hyperkalemia | 14 (20.3) | 6 (42.9) | 8 (57.1) |
| Dialysis frequency (per week), | |||
| Only once | 33 (47.8) | 13 (39.4) | 20 (60.6) |
| Twice | 36 (52.2) | 24 (66.7) | 12 (33.3) |
| Vascular access, | |||
| Right IJV catheter | 57 (82.6) | 34 (59.7) | 23 (40.3) |
| Arteriovenous fistula | 9 (13.0) | 2 (22.2) | 7 (77.8) |
| Permanent central catheter | 3 (4.4) | 1 (33.3) | 2 (67.7) |
| Causes of kidney failure, | |||
| CKD of unknown cause | 23 (33.3) | 12 (52.2) | 11 (47.8) |
| Diabetes | 16 (23.2) | 11 (68.7) | 5 (31.3) |
| Hypertension | 8 (11.6) | 4 (50.0) | 4 (50.0) |
| Sepsis | 7 (10.1) | 4 (57.1) | 3 (42.8) |
| RPGN | 4 (5.9) | 0 (0.00) | 4 (100.0) |
| Obstructive uropathy | 3 (4.4) | 2 (66.7) | 1 (33.3) |
| Others | 8 (11.7) | 4 (50.0) | 4 (50.0) |
Event represents death of patients and censored includes cured, defaulted, transferred, transplanted, and those who are still on dialysis. AKI: acute kidney injury, CKD: chronic kidney disease, HIV: human immune deficiency virus, IJVC: internal jugular vein catheter. SD: standard deviations, LOS: length of stay. Uremic features include symptoms such as persistent nausea/vomiting, fatigue, anorexia, mental status changes, pruritus, and pericarditis. Other causes of kidney failure include drug nephrotoxicity (n = 2), HIV infection (n = 2), hypertensive disorders of pregnancy (n = 2), prerenal AKI, and malaria (n = 1 each), and others in address represent 1 Afar region and 3 Amhara regions.
Figure 2Outcomes of patients enrolled to the haemodialysis centre of Ayder Hospital in the year 2021.
Figure 3Data from Ayder Hospital haemodialysis centre registry displaying number of haemodialysis sessions delivered (upper) and number of patients enrolled to haemodialysis centre (lower) in each consecutive year from 2016 to 2021.
Figure 4A picture of Ayder Hospital's haemodialysis centre displaying empty beds and having no patients connected to the haemodialysis machine due to lack of haemodialysis consumables.